Pharmacological inhibition of soluble epoxide hydrolase ameliorates diet-induced metabolic syndrome in rats.

Pharmacological inhibition of soluble epoxide hydrolase ameliorates diet-induced metabolic syndrome in rats.
复制标题

DOI:
10.1155/2012/758614
复制
发表时间:
2012
影响因子:
--
通讯作者:
Brown L
Brown L
中科院分区:
其他
文献类型:
--
作者:
Iyer A;Kauter K;Alam MA;Hwang SH;Morisseau C;Hammock BD;Brown L

文献摘要

参考文献

被引文献

相似文献

慢性大量营养素摄入过量后的代谢综合征体征包括体重增加、内脏脂肪沉积过多、高血脂症、葡萄糖和胰岛素不耐受、高血压、血脂异常、内皮损伤、心血管肥大、炎症、心室收缩功能障碍、纤维化和脂肪肝疾病。近年来的研究表明,可溶性环氧化物水解酶(sEH)的活性增加,在肥胖和代谢功能障碍。我们已经在饮食诱导的代谢综合征大鼠模型中测试了sEH抑制是否具有治疗潜力。在这些高碳水化合物、高脂肪喂养的大鼠中,长期口服反式-4-[4-(4-氨基苯基)-2-甲基-3-氧代-3-甲基-2-氧代-3-氧代-4(3-金刚烷-1-脲基)-环己氧基]-苯甲酸(t-AUCB)是一种有效的sEH抑制剂,其减轻体内代谢综合征的体征,包括葡萄糖、胰岛素和脂质异常,胰腺结构的变化,收缩压升高,心血管结构和功能异常,以及肝脏的结构和功能变化。本研究描述了这种选择性sEH抑制剂在具有饮食诱导的代谢综合征体征的大鼠中的药理学反应。
The signs of metabolic syndrome following chronic excessive macronutrient intake include body weight gain, excess visceral adipose deposition, hyperglycaemia, glucose and insulin intolerances, hypertension, dyslipidaemia, endothelial damage, cardiovascular hypertrophy, inflammation, ventricular contractile dysfunction, fibrosis, and fatty liver disease. Recent studies show increased activity of soluble epoxide hydrolase (sEH) during obesity and metabolic dysfunction. We have tested whether sEH inhibition has therapeutic potential in a rat model of diet-induced metabolic syndrome. In these high-carbohydrate, high-fat-fed rats, chronic oral treatment with trans-4-[4-(3-adamantan-1-ylureido)-cyclohexyloxy]-benzoic acid (t-AUCB), a potent sEH inhibitor, alleviated the signs of metabolic syndrome in vivo including glucose, insulin, and lipid abnormalities, changes in pancreatic structure, increased systolic blood pressure, cardiovascular structural and functional abnormalities, and structural and functional changes in the liver. The present study describes the pharmacological responses to this selective sEH inhibitor in rats with the signs of diet-induced metabolic syndrome.
DOI: 10.1080/07853890500415358
发表时间: 2006-01-01
期刊: ANNALS OF MEDICINE
影响因子: 4.4
作者:
Ferrannini, E
通讯作者: Ferrannini, E
DOI: 10.1038/nm0597-562
发表时间: 1997-05-01
期刊: NATURE MEDICINE
影响因子: 82.9
作者:
Moghaddam, MF;Grant, DF;Hammock, BD
通讯作者: Hammock, BD
DOI: 10.1111/j.1476-5381.2010.00637.x
发表时间: 2010-04-01
影响因子: 7.3
作者:
Iyer, Abishek;Fenning, Andrew;Brown, Lindsay
通讯作者: Brown, Lindsay
DOI: 10.1097/fjc.0b013e3181feb90a
发表时间: 2011-05-01
影响因子: 3
作者:
Panchal, Sunil K.;Poudyal, Hemant;Brown, Lindsay
通讯作者: Brown, Lindsay
DOI: 10.1038/345634a0
发表时间: 1990-06-14
期刊: NATURE
影响因子: 64.8
作者:
HABENICHT, AJR;SALBACH, P;GLOMSET, JA
通讯作者: GLOMSET, JA